Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer. [electronic resource]
Producer: 20121016Description: 755-61 p. digitalISSN:- 1525-1438
- Animals
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis -- drug effects
- Blotting, Western
- Caspase 9 -- metabolism
- Cell Adhesion -- drug effects
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Cisplatin -- pharmacology
- Down-Regulation
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Regulation, Neoplastic
- Glycoproteins -- antagonists & inhibitors
- Humans
- Mice
- NIH 3T3 Cells
- Neoplasm Invasiveness
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- pharmacology
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- RNA, Small Interfering -- genetics
- Radiation-Sensitizing Agents -- pharmacology
- Signal Transduction
- Tumor Cells, Cultured
- Tumor Stem Cell Assay
- Wnt Proteins -- antagonists & inhibitors
- bcl-X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.